181 related articles for article (PubMed ID: 24967199)
1. Aqueous levels of erythropoietin in acute retinal vein occlusion with macular edema.
Shin HJ; Kim HC; Moon JW
Int J Ophthalmol; 2014; 7(3):501-6. PubMed ID: 24967199
[TBL] [Abstract][Full Text] [Related]
2. Aqueous semaphorin 3A level correlates with retinal macular oedema and ganglion cell degeneration in patients with retinal vein occlusion.
Guo S; Ren J; Li Z; Fan X; Qin L; Li J
Acta Ophthalmol; 2019 May; 97(3):273-278. PubMed ID: 30803163
[TBL] [Abstract][Full Text] [Related]
3. Vitreal levels of erythropoietin are increased in patients with retinal vein occlusion and correlate with vitreal VEGF and the extent of macular edema.
Stahl A; Buchwald A; Martin G; Junker B; Chen J; Hansen LL; Agostini HT; Smith LE; Feltgen N
Retina; 2010 Oct; 30(9):1524-9. PubMed ID: 20664492
[TBL] [Abstract][Full Text] [Related]
4. Differences in aqueous concentrations of cytokines in macular edema secondary to branch and central retinal vein occlusion.
Feng J; Zhao T; Zhang Y; Ma Y; Jiang Y
PLoS One; 2013; 8(7):e68149. PubMed ID: 23861862
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of visual prognosis and correlative factors in retinal vein occlusion].
Zhang H; Xia Y
Zhonghua Yan Ke Za Zhi; 2002 Feb; 38(2):98-102. PubMed ID: 11955310
[TBL] [Abstract][Full Text] [Related]
6. Impact of cardiovascular risk factors on incidence and severity of Retinal Vein Occlusion.
Pacella F; Bongiovanni G; Malvasi M; Trovato Battagliola E; Pistone A; Scalinci SZ; Basili S; La Torre G; Pacella E
Clin Ter; 2020; 171(6):e534-e538. PubMed ID: 33151253
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive, High-Resolution Functional Macular Imaging in Subjects With Retinal Vein Occlusion.
Campagnoli TR; Somfai GM; Tian J; DeBuc DC; Smiddy WE
Ophthalmic Surg Lasers Imaging Retina; 2017 Oct; 48(10):799-809. PubMed ID: 29020423
[TBL] [Abstract][Full Text] [Related]
8. Photocoagulation for retinal vein occlusion.
Hayreh SS
Prog Retin Eye Res; 2021 Nov; 85():100964. PubMed ID: 33713810
[TBL] [Abstract][Full Text] [Related]
9. Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort.
Petrella RJ; Blouin J; Davies B; Barbeau M
J Ophthalmol; 2012; 2012():723169. PubMed ID: 23097691
[TBL] [Abstract][Full Text] [Related]
10. Comparison of subfoveal choroidal thickness in eyes with CRVO and BRVO.
Tang F; Xu F; Zhong H; Zhao X; Lv M; Yang K; Shen C; Huang H; Lv J; Zeng S; Li M; Chen Q
BMC Ophthalmol; 2019 Jun; 19(1):133. PubMed ID: 31226968
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up. (BERVOLT study: Bevacizumab for RVO long-term follow-up).
Kornhauser T; Schwartz R; Goldstein M; Neudorfer M; Loewenstein A; Barak A
Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):835-44. PubMed ID: 26269374
[TBL] [Abstract][Full Text] [Related]
12. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intravitreal bevacizumab with intravitreal triamcinolone acetonide for treatment of cystoid macular edema secondary to retinal vein occlusion: a Meta-analysis.
Sun Y; Qu Y
Int J Ophthalmol; 2015; 8(6):1234-9. PubMed ID: 26682180
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Pro Re Nata regimen without loading dose ranibizumab injections in retinal vein occlusion.
Unsal E; Eltutar K; Sultan P; Gungel H
Pak J Med Sci; 2015; 31(3):510-5. PubMed ID: 26150834
[TBL] [Abstract][Full Text] [Related]
15. Relationship between blood-aqueous barrier disruption and ischemic macular edema in patients with branch or central retinal vein occlusion: effects of sub-tenon triamcinolone acetonide injection.
Asano S; Miyake K; Miyake S; Ota I
J Ocul Pharmacol Ther; 2007 Dec; 23(6):577-84. PubMed ID: 18001246
[TBL] [Abstract][Full Text] [Related]
16. The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes.
Rao J; Wu N; Qu X; Hu Y; Wu Y; Cheng Y; Yan L; Huang H; Li S; Shi L; Wu X
Ophthalmic Res; 2021; 64(2):237-245. PubMed ID: 32506058
[TBL] [Abstract][Full Text] [Related]
17. Association of aqueous humor cytokines with the development of retinal ischemia and recurrent macular edema in retinal vein occlusion.
Jung SH; Kim KA; Sohn SW; Yang SJ
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2290-6. PubMed ID: 24398091
[TBL] [Abstract][Full Text] [Related]
18. Effect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusion.
Rezar-Dreindl S; Eibenberger K; Pollreisz A; Bühl W; Georgopoulos M; Krall C; Dunavölgyi R; Weigert G; Kroh ME; Schmidt-Erfurth U; Sacu S
Acta Ophthalmol; 2017 Mar; 95(2):e119-e127. PubMed ID: 27417275
[TBL] [Abstract][Full Text] [Related]
19. Foveal Eversion is Associated with High Persistence of Macular Edema and Visual Acuity Deterioration in Retinal Vein Occlusion.
Arrigo A; Aragona E; Antropoli A; Bianco L; Rosolia A; Saladino A; Bandello F; Battaglia Parodi M
Ophthalmol Ther; 2023 Aug; 12(4):2157-2169. PubMed ID: 37294523
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
Eter N; Mohr A; Wachtlin J; Feltgen N; Shirlaw A; Leaback R;
Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):77-87. PubMed ID: 27460280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
